CAS 691868-88-9

Formula: C14H5F6N5O

InChI: InChI=1S/C14H5F6N5O/c15-13(16,17)7-3-9(14(18,19)20)23-11-6(7)1-2-10-22-8(4-25(10)11)12-24-21-5-26-12/h1-5H

InChI key: GRHYZVJEXKTJOS-UHFFFAOYSA-N

SMILES: C1=CC2=NC(=CN2C3=C1C(=CC(=N3)C(F)(F)F)C(F)(F)F)C4=NN=CO4

RO8191

CAS: 691868-88-9

RO8191

Formula: C₁₄H₅F₆N₅O

Purity: ≥98%

Molecular weight: 373.21

Ref: 54-BUP08228

2-[2,4-Bis(Trifluoromethyl)Imidazo[1,2-A]1,8-Naphthyridin-8-Yl]-1,3,4-Oxadiazole

CAS: 691868-88-9

2-[2,4-Bis(Trifluoromethyl)Imidazo[1,2-A]1,8-Naphthyridin-8-Yl]-1,3,4-Oxadiazole

Formula: C₁₄H₅F₆N₅O

Purity: 90%

Molecular weight: 373.21

Ref: 54-PC108850

RO8191

CAS: 691868-88-9

Formula: C₁₄H₅F₆N₅O

Purity: 90%

Color and Shape: Solid

Molecular weight: 373.2128

Ref: IN-DA00G21X

RO8191

CAS: 691868-88-9

2-[2,4-Bis(trifluoromethyl)imidazo[1,2-a]1,8-naphthyridin-8-yl]-1,3,4-oxadiazole

Formula: C₁₄H₅F₆N₅O

Purity: 90%

Molecular weight: 373.21

Ref: IN-DG00871824

RO8191

CAS: 691868-88-9

RO8191 (CDM-3008) (CDM-3008) is an agonist of interferon (IFN) receptor.

Formula: C₁₄H₅F₆N₅O

Purity: 98.15% - 98.85%

Color and Shape: Yellow Solid

Molecular weight: 373.2128

Ref: TM-T22142

8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE

CAS: 691868-88-9

Purity: 90%

Molecular weight: 373.2179871

Ref: 10-F863736

RO8191

CAS: 691868-88-9

RO8191 is a small molecule that has been shown to inhibit replication of hepatitis B virus (HBV) in vitro and in vivo. RO8191 has also been shown to inhibit replication of human papillomavirus (HPV) and cervical cancer cells. In cellular systems, RO8191 inhibits the activity of cellular polymerase chain reaction (PCR) replicons, which are used as a model for HBV and HPV replication. The compound also inhibits the activity of replicons derived from human immunodeficiency virus type 1 (HIV-1). In vivo, RO8191 inhibited viral load in mice infected with HBV. Mesenchymal stromal cells (MSCs) have been shown to express high levels of RO8191's target enzyme, poly(ADP-ribose) polymerase 1 (PARP-1), suggesting that MSCs may be an effective delivery vehicle for this drug. This drug has not yet been evaluated for

Formula: C₁₄H₅F₆N₅O

Purity: Min. 95%

Molecular weight: 373.21 g/mol

Ref: 3D-RCB86888